DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Applicant: Astrazeneca

Summary for Applicant: Astrazeneca

Patents:47
Tradenames:74
Ingredients:66
NDAs:161
Drug Master File Entries: (click here to view)4
drug patent expirations by year for
 Astrazeneca
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Astrazeneca
XYLOCAINE
lidocaine hydrochloride
Injectable; Injection006488Approved prior to Jan 1, 1982RXYes<disabled><disabled>
Astrazeneca
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
Injectable; Injection006488Approved prior to Jan 1, 1982RXYes<disabled><disabled>
Astrazeneca
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
Injectable; Injection006488Nov 13, 1986RXYes<disabled><disabled>
Astrazeneca
AQUASOL A
vitamin a palmitate
Injectable; Injection006823Approved prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc